Colin Sambrook Smith has been appointed to the newly created role of head of computational chemistry and informatics at Sygnature Discovery. Mr. Smith has 26 years of R&D experience mostly within the pharmaceutical industry. Most recently he served as director of research technologies at OSI Prosidion, where he was responsible for informatics, computational chemistry, array chemistry and analytical chemistry. He was also a member of the Research Steering Group, which set and reviewed all research priorities and goals for the company.
 
Simon Hirst, Sygnature’s chief executive officer, said, “I am delighted to welcome Colin to Sygnature Discovery. He is a great addition to our management team. Colin is an experienced computational chemist and research manager with a proven ability to analyze and determine the scientific computing and information technology needs of research-based organizations. Colin is already contributing his expertise into several on-going projects and is managing a new, fully-integrated drug discovery program for a European biotech company.”